Axogen, Inc. Reports 2024 Fourth Quarter and Full-Year Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- JetBlue shares fall amid American results, fuel cost concerns
AxoGen, Inc. (AXGN) PT Raised to $25 at Raymond James
February 25, 2025 4:00 PM ESTRaymond James analyst Jayson Bedford raised the price target on AxoGen, Inc. (NASDAQ: AXGN) to $25.00 (from $23.00) while maintaining a Outperform rating.
The analyst comments "AXGNs initial 2025 guidance was well above our expectation and the investor day preview (highlighted by an expectation of... More
AxoGen, Inc. (AXGN) PT Raised to $25 at Leerink Partners
February 25, 2025 1:07 PM ESTLeerink Partners analyst Mike Kratky raised the price target on AxoGen, Inc. (NASDAQ: AXGN) to $25.00 (from $18.00) while maintaining a Outperform rating.
The analyst comments "Bottom Line: We are reiterating our Outperform rating on AXGN and increasing our PT to $25 (from $18) following the company's 4Q24 earnings. Consistent with its preannouncement (see HERE),... More



